Gainers
- Cerus, Inc. CERS stock moved upwards by 9.3% to $5.90 during Friday's pre-market session. The market value of their outstanding shares is at $511.9 million. The most recent rating by Stephens & Co., on August 23, is at Overweight, with a price target of $8.00.
- Obalon Therapeutics, Inc. OBLN shares moved upwards by 4.1% to $2.30. The market cap stands at $42.3 million.
- Viveve Medical, Inc. VIVE shares rose 2.7% to $0.13. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
Losers
- Jaguar Health, Inc. JAGX stock fell 6.8% to $1.10 during Friday's pre-market session. The market value of their outstanding shares is at $9.3 million.
- TrovaGene, Inc. TROV shares decreased by 5.1% to $2.25.
- Novavax, Inc. NVAX stock declined 3.5% to $6.40.
- Seelos Therapeutics, Inc. SEEL stock declined 2.8% to $1.73. The market value of their outstanding shares is at $60.8 million.
- CannTrust Holdings, Inc. CTST shares declined 2.1% to $1.89. The market cap stands at $320.7 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.